Prunus cerasus (Rosaceae) Sour Cherry, Tart Cherry, Montmorency
Prunus cerasus is the temperate fruit tree whose fruit has generated an unusually robust human clinical literature for a botanical, though the evidence remains concentrated on a narrow set of outcomes. Randomized controlled trials and a 2023 GRADE-assessed meta-analysis of 21 trials indicate that tart cherry products can reduce serum C-reactive protein (CRP) with moderate certainty and tumor necrosis factor-alpha (TNF-α) with very low certainty, but do not significantly affect blood pressure, heart rate, high-sensitivity CRP, or interleukin-6 . The fruit and seed extracts have demonstrated gastroprotective, anti-inflammatory, and antinociceptive activity in animal models comparable to ranitidine and ibuprofen . Traditional Cherokee medicine used the bark for colds, coughs, fevers, and gastrointestinal complaints, and the fruit stalks are recognized by the European Medicines Agency as a traditional diuretic . However, the kernel contains hydrocyanic acid and amygdalin, and the plant's safety profile requires careful distinction between the fruit, the stalk, and the toxic seed .
---
1. Taxonomic Insights
Species: Prunus cerasus L.
Family: Rosaceae (Rose Family)
Genus: Prunus
Synonyms: Cerasus vulgaris Mill., Cerasus acida (Ehrh.) Borkh.
Taxonomic Note: P. cerasus is an allotetraploid species derived from ancient hybridization between P. avium (sweet cherry) and P. fruticosa (ground cherry). This hybrid origin is reflected in its intermediate morphology and its ability to thrive in colder, wetter climates than sweet cherry.
---
Botanical Description
Prunus cerasus is a smaller tree than sweet cherry, typically reaching 4 to 10 metres, with a rounded crown and somewhat drooping branches. The bark is reddish-brown and smooth when young, becoming darker and rougher with age.
Key Identification Features:
Leaves are ovate to obovate, 5 to 10 centimetres long, with serrate margins and a short, often glandular petiole. Flowers are white, borne in umbels of 2 to 4, appearing with the leaves in spring. The fruit is a drupe, 1.5 to 2.5 centimetres in diameter, bright red to dark red at maturity, with a soft, acidic flesh and a rounded stone. The 'Montmorency' cultivar is the most widely studied and commercially important, producing bright red, tart fruit.
Distribution: Native to Europe and western Asia. Widely cultivated in temperate regions worldwide, particularly in North America (Michigan, Utah, Wisconsin), Europe (Poland, Germany, Serbia), and parts of Asia.
Conservation Status: Not assessed as threatened. Extensively cultivated and naturalized in many temperate regions.
---
Etymology
The generic name Prunus is the classical Latin name for the plum. The specific epithet cerasus is derived from the Greek kerasos, the ancient name for the cherry tree, ultimately from a pre-Greek Anatolian source.
---
2. Common Names
Scientific Name: Prunus cerasus | English: Sour Cherry, Tart Cherry, Pie Cherry, Montmorency (cultivar) | German: Sauerkirsche, Weichsel | French: Griottier, Cerisier Acide | Spanish: Guindo, Cerezo Ácido | Italian: Amarena, Visciola | Portuguese: Ginjeira | Chinese: 酸樱桃 | Japanese: スミミザクラ | Russian: Вишня обыкновенная
---
3. Related Herbs from the Rosaceae Family
Prunus avium (Sweet Cherry): The parent species of P. cerasus, with a sweeter fruit and higher cyanogenic glycoside content in non-fruit parts.
Prunus serotina (Black Cherry): A North American species with traditional medicinal bark use and similar cyanogenic toxicity concerns.
Crataegus monogyna (Hawthorn): A medicinal Rosaceae shrub with well-documented cardiovascular applications, representing the family's broader medicinal potential.
The Rosaceae family is characterized by diverse phenolic compounds, cyanogenic glycosides, and triterpenoids, with many species producing edible fruits and others serving as important medicinal plants.
---
4. Medicinal Uses: Summary of Primary and Secondary Actions
Primary Actions (Human Clinical Evidence):
Anti-inflammatory (Fruit): A 2023 GRADE-assessed systematic review and meta-analysis of 21 randomized controlled trials found that tart cherry significantly reduced serum CRP (WMD -0.39 mg/L, 95% CI -0.74 to -0.05, P = 0.024) with moderate certainty, and reduced TNF-α (WMD -0.14 pg/mL, 95% CI -0.27 to -0.02, P = 0.026) with very low certainty. Dose-response analysis suggested each 30 mL increase in dose reduced CRP by 0.19 mg/L. However, tart cherry did not affect blood pressure, heart rate, high-sensitivity CRP, or interleukin-6 .
Diuretic (Fruit Stalks): The European Medicines Agency (EMA) has assessed cherry stalks (P. avium and P. cerasus peduncles as exchangeable) as having sufficient evidence for traditional use as a diuretic, with more than 30 years of use in the EU, including at least 15 years . An in vivo rat study measured a diuretic effect using furosemide as positive control .
Secondary Actions (Preclinical and Traditional):
· Gastroprotective (Fruit and Seed): The ethyl acetate fruit extract (Scf), seed extract (Scs), cyanidin-3-glucoside (Cy3G), and linoleic acid (LA) significantly protected gastric mucosa against HCl/EtOH-induced lesions. Scs at 200 mg/kg showed the most gastroprotective potential, comparable to ranitidine at 50 mg/kg .
· Anti-inflammatory and Antinociceptive (Fruit and Seed): Scf, Scs, Cy3G, and LA showed significant anti-inflammatory and antinociceptive effects against carrageenan-induced edema and nociceptive pain. Scs at 200 mg/kg showed the most potent effects, comparable to ibuprofen at 100 mg/kg. The mechanism involves reduction of pro-inflammatory TNF-α and IL-6, elevation of anti-inflammatory IL-10, and amelioration of oxidative stress markers .
· Traditional Cherokee Medicine (Bark, Root Bark, Fruit): Documented uses include blood tonic, cold remedy, cough medicine, dermatological aid (astringent root bark wash for sores and ulcers), febrifuge, gastrointestinal aid (boiled fruit for bloody bowel discharge), gynecological aid (warm infusion at labor onset), oral aid (thrush), and throat aid (laryngitis) .
· Ayurvedic Uses: Fruit as diuretic and anti-inflammatory for genitourinary inflammations, cystitis, and urine retention; bark as febrifuge and antidiarrheal; fruit stalk as diuretic and pectoral; kernel as nervine; leaf infusion for convulsions in children .
---
Medicinal Parts
Fruit: The primary studied part. Rich in anthocyanins (cyanidin-3-glucoside) and other phenolics. Human trials support anti-inflammatory effects on CRP and TNF-α . Animal studies support gastroprotective, anti-inflammatory, and antinociceptive activity .
Fruit Stalks (Peduncles): EMA-recognized traditional diuretic . Traditionally used for renal stones, with caution advised due to increased urinary calcium, sodium, and chloride excretion .
Bark and Root Bark: Traditional Cherokee and Ayurvedic uses for fever, colds, coughs, diarrhea, and skin conditions .
Seed Kernel: Toxic. Contains hydrocyanic acid and amygdalin . However, a study on whole kernel meal in animals found no toxicity at doses up to 3000 mg/kg over 8 days and demonstrated protection against UV skin damage . This apparent contradiction reflects the difference between raw kernel consumption and processed kernel meal; raw kernels remain a cyanogenic risk.
Leaves: Contain amygdalin and are traditionally used for convulsions in children in Ayurveda .
---
5. Phytochemistry
5.1 Anthocyanins (Fruit)
Cyanidin-3-glucoside (Cy3G) was identified as the most active constituent in the fruit extract, responsible for gastroprotective, anti-inflammatory, and antinociceptive effects in animal models . Other anthocyanins include cyanidin-3-rutinoside and peonidin derivatives, contributing to the red color and antioxidant capacity.
5.2 Fatty Acids (Seed)
Linoleic acid (LA) was identified as the most active constituent in the seed extract, contributing to the gastroprotective, anti-inflammatory, and antinociceptive activity . A 2026 in silico study characterized the seed oil's major fatty acids (linoleic, oleic, palmitic, and stearic acids) and predicted favorable safety profiles, including non-mutagenicity and non-hepatotoxicity, with linoleic acid predicted to cross the blood-brain barrier .
5.3 Other Phenolics (Fruit)
The fruit contains flavonols (quercetin, kaempferol glycosides), flavan-3-ols (catechin, epicatechin), and phenolic acids. These contribute to the antioxidant and anti-inflammatory properties observed in human trials .
5.4 Cyanogenic Glycosides (Leaves, Kernel)
The kernel contains a considerable proportion of hydrocyanic acid, and the leaves contain amygdalin . These compounds are toxic and require careful processing to avoid cyanide poisoning.
5.5 Tannins (Bark)
The bark contains 5 to 7% tannin, contributing to its astringent and traditional dermatological uses .
---
6. Mechanisms of Action
6.1 Anti-inflammatory Activity
The anti-inflammatory effects are mediated through reduction of pro-inflammatory cytokines TNF-α and IL-6, elevation of anti-inflammatory IL-10, increased serum catalase and reduced glutathione levels, and decreased lipid peroxidation. The spleen regenerative capacity and oxidative stress amelioration appear to be key mechanisms . In human trials, the reduction in CRP suggests a systemic anti-inflammatory effect, though the effect size is modest .
6.2 Gastroprotective Activity
The gastroprotective mechanism involves protection of the gastric mucosa against HCl/EtOH-induced lesions, with histopathological evidence of regeneration. The seed extract at 200 mg/kg was comparable to ranitidine, suggesting a mechanism involving mucosal protection and antioxidant activity rather than acid suppression alone .
6.3 Antinociceptive Activity
The antinociceptive effect against carrageenan-induced pain was comparable to ibuprofen, suggesting involvement of anti-inflammatory pathways (reduction of prostaglandins and cytokines) rather than direct opioid mechanisms .
6.4 Diuretic Activity (Fruit Stalks)
The diuretic effect was measured in vivo in rats using furosemide as positive control . The mechanism likely involves increased renal excretion of water and electrolytes, though the EMA assessment notes that the effect on calcium, sodium, and chloride excretion was within normal values in the limited study population.
---
7. Traditional and Ethnobotanical Uses
7.1 Colds, Coughs, and Fevers (Bark, Cherokee)
Formulation: Infusion of bark.
Preparation and Use: The Cherokee used an infusion of bark for colds and coughs, and an infusion or decoction of bark for fevers, including the "great chill" .
Scientific Validation: No modern clinical studies on the bark for these indications. The traditional use is ethnobotanical.
7.2 Gastrointestinal Complaints (Fruit and Bark, Cherokee and Ayurveda)
Formulation: Boiled fruit; bark preparations.
Preparation and Use: The Cherokee used boiled fruit for "blood discharged from bowels" and in steam baths for indigestion, biliousness, and jaundice . Ayurveda uses the bark as an antidiarrheal .
Scientific Validation: The animal study demonstrating gastroprotective effects of fruit and seed extracts provides preclinical support for gastrointestinal use, though the traditional preparations differ from the extracts studied.
7.3 Diuretic (Fruit Stalks, EMA-recognized)
Formulation: Decoction of peduncles.
Preparation and Use: Cherry stalks are used as a traditional diuretic. The EMA assessment confirms traditional use status for this indication .
Scientific Validation: In vivo rat study demonstrated diuretic effect . The EMA notes caution in patients with kidney stones due to increased urinary calcium excretion.
7.4 Skin Sores and Ulcers (Root Bark, Cherokee)
Formulation: Astringent root bark wash.
Preparation and Use: Root bark used as a wash for old sores and ulcers .
Scientific Validation: The tannin content (5–7% in bark) provides a plausible astringent mechanism, but no modern studies were found.
7.5 Other Traditional Uses
The Cherokee also used warm infusion at the onset of labor pains, a compound of barks in corn whiskey for measles, an infusion for thrush, and a decoction of inner bark for laryngitis . Ayurveda uses the kernel as a nervine and leaf infusion for convulsions in children .
---
8. Healing Recipes, Teas, Decoctions, and Culinary Uses
Important Note: Only the ripe fruit and the fruit stalks (peduncles) are safe for consumption. The leaves, bark, and kernel contain cyanogenic compounds and should not be ingested without proper processing.
8.1 Tart Cherry Juice or Concentrate
Purpose: A palatable way to consume a concentrated dose of cherry phenolics, as used in clinical trials.
Preparation and Use: Commercial Montmorency tart cherry juice concentrate is the most studied form. The meta-analysis of 21 trials used various tart cherry products, with dose-response analysis suggesting each 30 mL increase reduced CRP by 0.19 mg/L .
8.2 Cherry Stalk Decoction (Traditional Diuretic)
Formulation: Decoction of peduncles.
Preparation and Use: Dried cherry stalks are simmered in water and consumed as a diuretic. The EMA recognizes this traditional use .
Caution: Use with caution in patients with kidney stones due to increased urinary calcium excretion. Not recommended for children under 18 or during pregnancy/breastfeeding due to lack of data .
8.3 Fresh Sour Cherries and Culinary Uses
The fruit is consumed fresh (though tart), or processed into pies, jams, jellies, juices, and liqueurs. The 'Montmorency' cultivar is the standard for pie cherries.
---
9. Clinical Significance and Evidence Summary
9.1 Evidence Hierarchy by Activity
Anti-inflammatory (Fruit, CRP): Moderate certainty from a GRADE-assessed meta-analysis of 21 RCTs. Tart cherry reduces serum CRP by -0.39 mg/L .
Anti-inflammatory (Fruit, TNF-α): Very low certainty from the same meta-analysis. Reduction of -0.14 pg/mL .
Blood Pressure / Heart Rate: No significant effect according to the meta-analysis .
Diuretic (Fruit Stalks): EMA-recognized traditional use with in vivo animal support .
Gastroprotective, Anti-inflammatory, Antinociceptive (Fruit and Seed): Strong preclinical evidence from animal models, with effects comparable to ranitidine and ibuprofen . No human clinical trials for these specific indications.
Critical Gap: Despite the relatively robust human trial literature for CRP and TNF-α, the clinical significance of a -0.39 mg/L CRP reduction is uncertain, and the very low certainty for TNF-α limits confidence. The traditional uses for bark and root bark have no modern clinical validation.
---
10. Safety and Toxicology
10.1 Toxicity Profile
Fruit: Generally recognized as safe as a food. Human trials report no serious adverse events .
Fruit Stalks: EMA assessment concludes cherry stalks can be safely used in usual dosage and traditional dosage form. Contraindicated in hypersensitivity. Not recommended in children under 18 or during pregnancy/breastfeeding due to lack of data. Use with caution in patients with kidney stones .
Seed Kernel: Contains hydrocyanic acid and amygdalin . Toxic if consumed raw. However, an animal study of whole kernel meal at doses up to 3000 mg/kg for 8 days found no evidence of toxicity and demonstrated UV-protective effects . This suggests that processed kernel meal may be safe, but raw kernels should be avoided.
Bark and Leaves: Contain amygdalin and cyanogenic compounds. Not for casual ingestion.
10.2 Contraindications and Precautions
Pregnancy and Lactation: Fruit is safe as food. Cherry stalk preparations are not recommended due to lack of data .
Kidney Stones: Cherry stalks increase urinary calcium excretion and should be used with caution .
Children: Cherry stalk preparations are not recommended under 18 years .
10.3 Potential Drug Interactions
No specific drug interaction studies were found for sour cherry. The theoretical potential for additive anti-inflammatory effects with NSAIDs or immunosuppressants exists based on the CRP/TNF-α data, but this has not been clinically established.
---
11. Quality Control Parameters
11.1 Marker Compounds for Standardisation
For Fruit: Cyanidin-3-glucoside is the most active constituent and a suitable marker . Total anthocyanins and total phenolics are functional markers.
For Seed: Linoleic acid is the most active constituent .
11.2 Recommended Analytical Methods
High-performance liquid chromatography (HPLC) for anthocyanin profiling and quantification. Gas chromatography (GC) for fatty acid profiling of seed oil.
11.3 Suggested Specifications
No official pharmacopoeial specifications exist for sour cherry fruit. For cherry stalk preparations, the EMA monograph provides the regulatory framework.
---
12. Cultivation and Sustainability
12.1 Growth Requirements
Climate: Temperate. More cold-hardy and moisture-tolerant than sweet cherry, thriving in regions with cold winters and cool springs.
Habitat: Deep, well-drained soils. Widely planted in orchards.
Propagation: Grafted onto rootstocks, often mahaleb (P. mahaleb) or colt rootstocks.
12.2 Sustainable Harvesting
Fruit is harvested by hand or mechanically. Stalks are collected as a byproduct of fruit processing, representing a valorization opportunity.
12.3 Conservation Status
Not assessed as threatened. Extensively cultivated.
---
13. Research Gaps and Future Directions
13.1 Critical Research Gaps
Clinical Significance of CRP Reduction: The -0.39 mg/L reduction in CRP is statistically significant but of uncertain clinical relevance. Trials with hard clinical endpoints are needed.
TNF-α Certainty: The very low certainty for TNF-α reduction means further high-quality trials are needed.
Traditional Bark Uses: No modern studies on the Cherokee and Ayurvedic uses of bark for fever, cough, and diarrhea.
Kernel Safety: The apparent safety of processed kernel meal contrasts with the known cyanogenic content of raw kernels. Research on safe processing methods and thresholds is needed.
13.2 Future Research Priorities
Anti-inflammatory: Larger, longer trials with standardized products and clinically relevant endpoints (e.g., in metabolic syndrome or arthritis populations).
Diuretic: Controlled clinical trials of cherry stalk preparations to confirm the EMA-recognized traditional use.
Kernel Valorization: Development of safe processing methods to utilize the kernel's UV-protective and anti-inflammatory potential without cyanogenic risk.
---
14. Commercial Applications
14.1 Pharmaceutical and Nutraceutical Potential
Tart Cherry Concentrate and Powders: The primary commercial form, marketed for anti-inflammatory and recovery benefits, with moderate certainty for CRP reduction .
Cherry Stalk Extracts: EMA-recognized traditional diuretic products, primarily in European markets .
14.2 Application-Specific Product Development
Functional Beverages: Tart cherry juice and concentrate for sports recovery and inflammation management.
Traditional Herbal Medicinal Products: Cherry stalk preparations for diuretic use, under the EMA traditional use framework.
---
15. Related Plants for Further Study
Prunus avium (Sweet Cherry): The parent species, with similar fruit phenolics but different cyanogenic profile and less clinical research.
Prunus serotina (Black Cherry): A North American species with traditional bark use and similar toxicity concerns.
---
16. Reference Literature
Primary Research
· Raafat, K., et al. (2019). "Gastroprotective and anti-inflammatory effects of Prunus cerasus phytochemicals and their possible mechanisms of action." Journal of Traditional and Complementary Medicine 10(4): 345-353. Key animal study identifying cyanidin-3-glucoside and linoleic acid as active constituents .
· Norouzzadeh, M., et al. (2023). "Dose-dependent effect of tart cherry on blood pressure and selected inflammation biomarkers: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials." Heliyon 9(9): e19987. Key human evidence synthesis .
· Kimble, R., et al. (2021). "The Influence of Tart Cherry (Prunus cerasus, cv Montmorency) Concentrate Supplementation for 3 Months on Cardiometabolic Risk Factors in Middle-Aged Adults: A Randomised, Placebo-Controlled Trial." Nutrients 13(5): 1417 .
· (2026). "In Vitro Anti-Inflammatory Activity of Sour Cherry (Prunus cerasus L.) Seed Oil and Computational Safety Profiling." Chemistry & Biodiversity. In silico safety data for seed oil fatty acids .
Regulatory and Ethnobotanical Sources
· EMA Assessment Report on Prunus avium L., Prunus cerasus L., peduncle (EMA/HMPC/379865/2023). Regulatory assessment of cherry stalk traditional use and safety .
· Native American Ethnobotany Database: Cherokee uses of P. cerasus .
· Khare, C. (2007). Indian Medicinal Plants. Springer. Ayurvedic uses and phytochemistry .
· MTMT: Animal toxicity study of sour cherry seed kernel meal .
---
17. Disclaimer
The ripe fruit of Prunus cerasus is generally recognized as safe for human consumption.
The leaves, bark, and raw kernel contain cyanogenic compounds and should not be ingested without proper processing. Processed kernel meal has shown safety in animal studies, but raw kernels remain a cyanide risk.
Cherry stalk preparations are recognized for traditional diuretic use but are not recommended during pregnancy or breastfeeding, or in children under 18, and should be used with caution in patients with kidney stones.
This information is for educational and academic purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
Medicinal applications beyond the EMA-recognized diuretic use of stalks and the moderate-certainty CRP reduction for the fruit lack definitive clinical validation for specific disease outcomes.
Proper identification is crucial. Always consult a qualified healthcare practitioner before using any plant for medicinal purposes.

Comments